Cargando…

Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer

Colorectal cancer (CRC) is one of the most common carcinomas with high morbidity and mortality worldwide. However, the underlying molecular mechanisms of CRC are unclear. The aim of the present study was to establish the role that overexpression of LBX2 serves in CRC and to investigate the associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiaodong, Yang, Yujie, Yang, Chao, Li, Huali, Cheng, Huangrong, Zheng, Yongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202318/ https://www.ncbi.nlm.nih.gov/pubmed/32382328 http://dx.doi.org/10.3892/ol.2020.11489

Ejemplares similares

CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety
por: Li, Huali, et al.
Publicado: (2021)

A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of Gastric Cancer: A Single-Center Retrospective Study
por: Yang, Chao, et al.
Publicado: (2020)

Overexpression of Long Noncoding RNA LBX2-AS1 Promotes the Proliferation of Colorectal Cancer
por: Li, Qing, et al.
Publicado: (2021)

Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer
por: Lin, Xiao-Lu, et al.
Publicado: (2017)

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2016)

LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance
por: Ma, Yu-Nan, et al.
Publicado: (2021)

Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer
por: Yu, Hongyan, et al.
Publicado: (2013)

Comparative genomics of Lbx loci reveals conservation of identical Lbx ohnologs in bony vertebrates
por: Wotton, Karl R, et al.
Publicado: (2008)

Apolipoprotein E Overexpression Is Associated With Tumor Progression and Poor Survival in Colorectal Cancer
por: Zhao, Zhixun, et al.
Publicado: (2018)

Retraction Note: LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance
por: Ma, Yu-Nan, et al.
Publicado: (2023)

Lbx2 regulates formation of myofibrils
por: Ochi, Haruki, et al.
Publicado: (2009)

LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2
por: Jia, Haipeng, et al.
Publicado: (2021)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Mutation in LBX1/Lbx1 precludes transcription factor cooperativity and causes congenital hypoventilation in humans and mice
por: Hernandez-Miranda, Luis Rodrigo, et al.
Publicado: (2018)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study
por: Huang, Feng, et al.
Publicado: (2020)

Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females
por: Huang, Yixiang, et al.
Publicado: (2018)

A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma
por: Yang, Chao, et al.
Publicado: (2021)

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors
por: Yin, Xiaonan, et al.
Publicado: (2019)

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer
por: Ni, Jun, et al.
Publicado: (2018)

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer
por: Zeng, Yan-Ru, et al.
Publicado: (2015)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
por: Cheang, Tuck-yun, et al.
Publicado: (2016)

Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer
por: Zhao, Jingkun, et al.
Publicado: (2017)

Overexpression of δ-catenin is associated with a malignant phenotype and poor prognosis in colorectal cancer
por: ZHANG, HONG, et al.
Publicado: (2015)

Overexpression of RACK1 Predicts Poor Prognosis in Melanoma
por: Shen, Congcong, et al.
Publicado: (2020)

The Susceptibility and Potential Functions of the LBX1 Gene in Adolescent Idiopathic Scoliosis
por: Luo, Ming, et al.
Publicado: (2021)

Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer
por: Cho, Hanbyoul, et al.
Publicado: (2014)

Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma
por: Chen, Jie, et al.
Publicado: (2013)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Role of Zebrafish Lbx2 in Embryonic Lateral Line Development
por: Chen, Xiaowen, et al.
Publicado: (2011)

Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2016)

Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer
por: Zhou, Yan-Wu, et al.
Publicado: (2018)

Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2015)

Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis
por: Huang, Chao, et al.
Publicado: (2020)

Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
por: Liu, Xuewen, et al.
Publicado: (2017)

Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer
por: Blondy, Sabrina, et al.
Publicado: (2020)

Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis
por: Chen, Siying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ht83qm468li0acpnnplpq52us3